Literature DB >> 1549631

Measurement of isometric force in children with and without Duchenne's muscular dystrophy.

C M Brussock1, S M Haley, T L Munsat, D B Bernhardt.   

Abstract

The purpose of this study was to examine the consistency of measurements of maximal isometric force production in children using an electronic strain gauge. A standardized protocol of force testing from the Tufts Quantitative Neuromuscular Examination was adapted to obtain isometric force measurements in seven muscle groups bilaterally. Ten children with Duchenne's muscular dystrophy (DMD) and 10 age-matched children without DMD were recruited for the study. A generalizability framework was used to examine variations in measurements attributable to group differences, test occasions within the same day, and extremity side. Intertester reliability estimates were also completed on a subsample of children with and without DMD. A three-way analysis of variance between groups, sides, and test occasions demonstrated a significant group main effect for all muscle groups. In general, significant main effects were not present for side or test occasion. Test-retest intraclass correlation coefficients (ICCs) for all muscle groups ranged from .88 to .99 for the children with DMD and from .85 to .98 for the children without DMD. Intertester ICCs were slightly lower, ranging from .74 to .97 for the children with DMD and from .71 to .98 for the children without DMD. The results indicate that the electronic strain-gauge protocol produces reproducible force measurements in seven selected muscle groups in children with and without DMD. Brussock CM, Haley SM, Munsat TL, Bernhardt DB. Measurement of isometric force in children with and without Duchenne's muscular dystrophy.

Entities:  

Mesh:

Year:  1992        PMID: 1549631     DOI: 10.1093/ptj/72.2.105

Source DB:  PubMed          Journal:  Phys Ther        ISSN: 0031-9023


  8 in total

1.  Patient reported outcomes in GNE myopathy: incorporating a valid assessment of physical function in a rare disease.

Authors:  Christina Slota; Margaret Bevans; Li Yang; Joseph Shrader; Galen Joe; Nuria Carrillo
Journal:  Disabil Rehabil       Date:  2017-02-07       Impact factor: 3.033

2.  Longitudinal assessment of grip strength using bulb dynamometer in Duchenne Muscular Dystrophy.

Authors:  Tatiana M Pizzato; Cyntia R J A Baptista; Mariana A Souza; Michelle M B Benedicto; Edson Z Martinez; Ana C Mattiello-Sverzut
Journal:  Braz J Phys Ther       Date:  2014-06-24       Impact factor: 3.377

Review 3.  Measures of adult and juvenile dermatomyositis, polymyositis, and inclusion body myositis: Physician and Patient/Parent Global Activity, Manual Muscle Testing (MMT), Health Assessment Questionnaire (HAQ)/Childhood Health Assessment Questionnaire (C-HAQ), Childhood Myositis Assessment Scale (CMAS), Myositis Disease Activity Assessment Tool (MDAAT), Disease Activity Score (DAS), Short Form 36 (SF-36), Child Health Questionnaire (CHQ), physician global damage, Myositis Damage Index (MDI), Quantitative Muscle Testing (QMT), Myositis Functional Index-2 (FI-2), Myositis Activities Profile (MAP), Inclusion Body Myositis Functional Rating Scale (IBMFRS), Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI), Cutaneous Assessment Tool (CAT), Dermatomyositis Skin Severity Index (DSSI), Skindex, and Dermatology Life Quality Index (DLQI).

Authors:  Lisa G Rider; Victoria P Werth; Adam M Huber; Helene Alexanderson; Anand Prahalad Rao; Nicolino Ruperto; Laura Herbelin; Richard Barohn; David Isenberg; Frederick W Miller
Journal:  Arthritis Care Res (Hoboken)       Date:  2011-11       Impact factor: 4.794

4.  Quantitative muscle strength assessment in duchenne muscular dystrophy: longitudinal study and correlation with functional measures.

Authors:  Alberto Lerario; Serena Bonfiglio; MariaPia Sormani; Andrea Tettamanti; Sarah Marktel; Sara Napolitano; Stefano Previtali; Marina Scarlato; MariaGrazia Natali-Sora; Eugenio Mercuri; Nereo Bresolin; Tiziana Mongini; Giancarlo Comi; Roberto Gatti; Fabio Ciceri; Giulio Cossu; Yvan Torrente
Journal:  BMC Neurol       Date:  2012-09-13       Impact factor: 2.474

5.  Muscle strength deficiency and mitochondrial dysfunction in a muscular dystrophy model of Caenorhabditis elegans and its functional response to drugs.

Authors:  Jennifer E Hewitt; Amelia K Pollard; Leila Lesanpezeshki; Colleen S Deane; Christopher J Gaffney; Timothy Etheridge; Nathaniel J Szewczyk; Siva A Vanapalli
Journal:  Dis Model Mech       Date:  2018-12-04       Impact factor: 5.758

6.  Quadriceps muscle strength in Duchenne muscular dystrophy and effect of corticosteroid treatment.

Authors:  Luciano Merlini; Ilaria Cecconi; Antonia Parmeggiani; Duccio Maria Cordelli; Ada Dormi
Journal:  Acta Myol       Date:  2020-12-01

7.  The 6-minute walk test and other clinical endpoints in duchenne muscular dystrophy: reliability, concurrent validity, and minimal clinically important differences from a multicenter study.

Authors:  Craig M McDonald; Erik K Henricson; R Ted Abresch; Julaine Florence; Michelle Eagle; Eduard Gappmaier; Allan M Glanzman; Robert Spiegel; Jay Barth; Gary Elfring; Allen Reha; Stuart W Peltz
Journal:  Muscle Nerve       Date:  2013-07-17       Impact factor: 3.217

8.  Relationships between muscle size, strength, and physical activity in adults with muscular dystrophy.

Authors:  Matthew F Jacques; Gladys L Onambele-Pearson; Neil D Reeves; Georgina K Stebbings; Jonathon Smith; Christopher I Morse
Journal:  J Cachexia Sarcopenia Muscle       Date:  2018-10-19       Impact factor: 12.910

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.